about
Treatment of refractory chronic GVHD with rituximab: a GITMO study.A risk prediction score for invasive mold disease in patients with hematological malignanciesClinical Impact of Hypomethylating Agents in the Treatment of Myelodysplastic Syndromes.Successful Treatment of Bilateral Endogenous Fusarium solani Endophthalmitis in a Patient with Acute Lymphocytic Leukemia.Changes in the incidence of candidemia and related mortality in patients with hematologic malignancies in the last ten years. A SEIFEM 2015-B report.Retrospective Cohort Analysis of Liposomal Amphotericin B Nephrotoxicity in Patients with Hematological Malignancies.Routine use of a real-time polymerase chain reaction method for detection of bloodstream infections in neutropaenic patients.Diagnosis of bloodstream infections in immunocompromised patients by real-time PCR.Radiologic findings of Fusarium pneumonia in neutropenic patients.ITA-MNGIE: an Italian regional and national survey for mitochondrial neuro-gastro-intestinal encephalomyopathy.High resolution computed tomography angiography improves the radiographic diagnosis of invasive mold disease in patients with hematological malignancies.Cost-effectiveness of blood culture and a multiplex real-time PCR in hematological patients with suspected sepsis: an observational propensity score-matched study.Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: a prospective study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO).Reduced incidence of GVHD without increase in relapse with low-dose rabbit ATG in the preparative regimen for unrelated bone marrow transplants in CML.Acute graft-versus-host disease and steroid treatment impair CD11c+ and CD123+ dendritic cell reconstitution after allogeneic peripheral blood stem cell transplantation.Aspergillus fumigatus suppresses the human cellular immune response via gliotoxin-mediated apoptosis of monocytes.Intensification of GVHD prophylaxis with low-dose ATG-F before allogeneic PBSC transplantation from HLA-identical siblings in adult patients with hematological malignancies: results from a retrospective analysis.Molecular monitoring of BCR-ABL transcripts after allogeneic stem cell transplantation for chronic myeloid leukemia.Zygomycosis in Italy: a survey of FIMUA-ECMM (Federazione Italiana di Micopatologia Umana ed Animale and European Confederation of Medical Mycology).Identification of an invasive infection of R. oryzae in a haematological patient using a molecular technique.Successful treatment of multi-resistant Pseudomonas aeruginosa osteomyelitis after allogeneic bone marrow transplantation with a combination of colistin and tigecycline.The utility of contrast-enhanced hypodense sign for the diagnosis of pulmonary invasive mould disease in patients with haematological malignancies.Computerized tomographic pulmonary angiography discriminates invasive mould disease of the lung from lymphoma.Computed tomographic pulmonary angiography for diagnosis of invasive mold diseases in patients with hematological malignancies.Acute Invasive Fungal Rhinosinusitis in Immunocompromised Patients: Role of an Early Diagnosis.An increased expression of PI-PLCβ1 is associated with myeloid differentiation and a longer response to azacitidine in myelodysplastic syndromesHairy cell leukemia: allogeneic transplantation could be an optimal option in selected patientsHigher numbers of blood CD14+ cells before starting conditioning regimen correlate with greater risk of acute graft-versus-host disease in allogeneic stem cell transplantation from related donorsSuccessful treatment of disseminated Fusariosis after allogeneic hematopoietic stem cell transplantation with the combination of voriconazole and liposomal amphotericin BUse of anti-BDCA-2 antibody for detection of dendritic cells type-2 (DC2) in allogeneic hematopoietic stem cell transplantationMorphologic changes leading to bronchiolitis obliterans in a patient with delayed non-infectious lung disease after allogeneic bone marrow transplantationDifferent immune reconstitution in multiple myeloma, chronic myeloid leukemia and acute myeloid leukemia patients after allogeneic transplantation of peripheral blood stem cellsDiscrepancy between serological complete remission and concomitant new bone lytic lesions after infusion of escalating low doses of donor lymphocytes in multiple myeloma: a case reportClinical relevance of acute pancreatitis in allogeneic hemopoietic stem cell (bone marrow or peripheral blood) transplantsAlloantigen presenting capacity, T cell alloreactivity and NK function of G-CSF-mobilized peripheral blood cellsImproved Radiographic Imaging of Invasive Fungal Disease: The Cornerstone to Antifungal Stewardship in the Hematology Units?Allotransplant in relapsed or refractory aggressive T-cell lymphomas: retrospective monocentric analysis of 14 patientsIn vivo T-cell depletion with low-dose ATG is effective in reducing cGVHD after peripheral blood stem cell myeloablative sibling transplants in CML: results from a prospective phase II studyAllergy to latexSystemic Infections Caused by Escherichia Coli in a Neutropenic Patient With Multiple TLR Gene Polymorphisms Abolished by Stem-Cell Transplantation
P50
Q33375484-5F3A19CC-54A5-4774-94BC-8EC506721ECAQ35005712-E64166C8-C9B2-4080-92F6-0F614CB2B509Q39934201-CB17F3A0-2C90-4621-AB9A-986B44C0A213Q40066606-B9CE0C83-B5F2-460D-A8FD-78009D55BA37Q40125779-175A813E-F499-4358-BE22-A1AC958CEB66Q40175242-DFDAE5B8-A17A-4325-9C78-5A8B40F7C573Q40266957-C6BD0562-31D1-46EF-96E3-4228E071F072Q40392515-467C28EA-CC3C-464C-99E0-2EDD1007484FQ40595985-2D84BA4D-64E4-4F0B-B9C0-9E9FFF76E6B4Q40837097-584833E5-89DC-4589-948C-4AFA40D9FB72Q41461503-18F3CE71-69C8-486F-868C-DAA642B51976Q42217659-D68D8E1B-AD1C-474E-9F29-7A82791FF1BFQ42223864-F5ADF262-A104-407F-98E4-50CD21A87F3AQ44511391-D503A45B-5C51-46F7-BEA9-BEE1F953F12BQ45119325-B09AB97F-B574-4892-91F8-66A9AC336E0FQ45152662-620918E9-8400-4918-828B-2DA7166102FAQ45851521-4C1B976C-E904-48DC-AFB6-0C1FA1369B33Q45868745-F94F48DE-832A-4B7A-BCDD-8904E55AD4A1Q45945768-79E1E26B-8118-4CAC-9B46-1B2D191B77DCQ46080531-4FDBB2E5-936F-48D7-9008-AAC137697E5CQ46885899-F323768E-2E11-40D9-84AF-68DFAE006D49Q48166344-5B6052E4-E4B7-4C2F-98FB-FC192FF8F584Q53018832-CC4A6C02-F756-44BF-BBD4-2A832C6492ECQ53185507-A8387529-D914-47F3-9FC6-F845794E82D2Q54252657-1B21F905-AD13-4D30-AE09-A61BAD1F8B15Q56967857-214BA8FF-05E7-40FD-AAFD-E039530A3E27Q56980886-5F8B1E0E-8D72-4146-928C-9D2D0D46F672Q56995846-30300A48-F33B-406C-AC00-237F407B4EC2Q56996769-CA382AD0-95E4-4099-A490-67422B1319BBQ57005578-530D3EF9-6D6D-4D6C-9F65-CA679615D372Q57006753-B30DEC01-254F-4EA2-9B45-A568FB481DAFQ57008819-BBEDD649-7075-4D9F-9C04-9BD73DD3ACB6Q57012014-1F976135-CA8C-45FC-A076-C46B7396133EQ57012407-B20E28D5-D4D0-4E5A-B692-7180284A2E0BQ57013837-7C86ACF4-38F6-4360-8209-8F08AD84E123Q57795721-CC4F2FC1-42B6-438B-A687-73AC975106FAQ59281233-037F7A48-C513-4B9A-B9D8-E7933D12A4C1Q59281255-0A915097-94F9-47F8-B6FE-7347247CBA7EQ59281328-FACFA76D-8D85-447B-9258-4D2768199B38Q59344692-59F658E0-EECF-4B1C-B17A-4CFF3BD67056
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Marta Stanzani
@ast
Marta Stanzani
@en
Marta Stanzani
@es
Marta Stanzani
@nl
type
label
Marta Stanzani
@ast
Marta Stanzani
@en
Marta Stanzani
@es
Marta Stanzani
@nl
prefLabel
Marta Stanzani
@ast
Marta Stanzani
@en
Marta Stanzani
@es
Marta Stanzani
@nl
P106
P1153
6603789144
P21
P31
P496
0000-0003-1569-3447